Diagnosis of Pneumocystis Carinii Pneumonia: Specificity and Sensitivity of Polymerase Chain Reaction in Comparison with Immunofluorescence in Bronchoalveolar Lavage Specimens
DNA amplification by the polymerase chain reaction (PCR) is a promising method for the detection of Pneumocystis carinii in immunosuppressed patients. The sensitivity and specificity of the PCR technique has been assessed in comparison with the immunofluoresence method (IF) on bronchoalveolar lavage fluid (BALF). Results correlated in 43 (78·8%) of 52 cases studied. P. carinii PCR gave positive results with BALF from all 32 patients found to have P. carinii pneumonia (PCP); IF gave positive results with 26 of them. PCR was more sensitive and as specific as IF. However, at the present time, we do not believe that it is clinically useful for detection of P. carinii in BALF samples. P. carinii DNA amplification by PCR should be reserved for testing IF-negative BALF samples from patients judged clinically to have PCP.
PetersBS,
BeckEJ,
ColemanDG et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ1991; 302:203–207
Jules-ElyseeKM,
StoverDE,
ZamanMB,
BernardEM,
WhiteDA.
Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med1990; 112:750–757
LevineSJ,
MasurH,
GillVJ et al. The effects of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am Rev Resp Dis1991; 144:760–764
WakefieldAE,
GuiverL,
MillerRF,
HopkinJM.
DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet1991; 337:1378–1379
KlechH,
PohlW.
eds Technical recommendations and guide lines for bronchoalveolar lavage (BAL): report of the European Society of Pneumology task group on BAL. Eur RespirJ1989; 2:561–585
SinclairK,
WakefieldAE,
BanerjiS,
HopkinJ.Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol1991; 45:183–184
SackettDL,
HaynesRB,
GuyattGH,
TugwellP. The in terpretation of diagnostic data. In
SackettDL,
HaynesRB,
GuyattGH,
TugwellP.
eds Clinical epidemiology: a basic science for clinical medicine. Boston/Toronto/ London: Little, Brown and Company; 199169–152
AntinoriA,
MurriR,
TamburriniE,
De LucaA,
OrtonaL.
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet1992; 340:788
HopewellPC.
Pneumocystis carinii pneumonia. Current con cepts. In
SandeMA,
VolberdingPA.
eds The medical management of AIDS Philadelphia, WB: Saunders Company; 1992261–283
LipschikGY,
GillVJ,
LundgrenJD et al. Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum or blood. Lancet1992; 340:203–206
BlumenfeldW,
McCookO,
HolodniyM,
KatzensteinDA.
Correlation of morphologic diagnosis of Pneumocystis carinii with the presence of pneumocystis DNA amplified by the polymerase chain reaction. Mod Pathol1992; 5:103–106
PetersSE,
WakefieldAE,
SinclairK,
MillardPR,
HopkinJ. A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol1992; 166:195–198
GoeschTR,
GotzG,
StellbrinckKH,
AlbrechtH,
WehHJ,
HossfeldDK.
Possible transfer of Pneumocystis carinii between immunodeficient patients. Lancet1990; 336:627
ChaveJ-P,
DavidS,
WautersJ-P,
Van MelleG,
FrancioliP.
Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS1991; 5:927–932
JacobsJL,
LibbyDM,
WintersRA et al. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med1991; 324:246–250
Diagnosis of Pneumocystis Carinii Pneumonia: Specificity and Sensitivity of Polymerase Chain Reaction in Comparison with Immunofluorescence in Bronchoalveolar Lavage Specimens